Results 141 to 150 of about 2,930 (198)

THE DMT–LASER INTERFERENCE PROTOCOL (Version 2): A Standardized, Open-Source Framework for Safe, Reproducible Investigation of Structured Visual Phenomena in Diffused Coherent Light Under N,N-Dimethyltryptamine

Swygert, John
openalex   +1 more source

Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of <i>N,N</i>-dimethyltryptamine and harmine in a meditation retreat. [PDF]

Imaging Neurosci (Camb)
Egger K, Meling D, Polat F, Seifritz E, Avram M, Scheidegger M.   +5 more
europepmc   +1 more source

Harnessing Pharmacogenomics in Clinical Research on Psychedelic-Assisted Therapy. [PDF]

Clin Pharmacol Ther
Halman A, Conyers R, Moore C, Khatri D, Sarris J, Perkins D.   +5 more
europepmc   +1 more source

Psychosis in a Military Veteran in the Context of Hallucinogen Use: A Case Report. [PDF]

Cureus
Parhami P, Moriarty SE, Parikh J, Galicki L.   +3 more
europepmc   +1 more source

<i>N</i>,<i>N</i>-dimethyltryptamine mitigates experimental stroke by stabilizing the blood-brain barrier and reducing neuroinflammation. [PDF]

Sci Adv
László MJ, Vigh JP, Kocsis AE, Porkoláb G, Hoyk Z, Polgár T, Walter FR, Szabó A, Djurovic S, Merkely B, Alpár A, Frecska E, Nagy Z, Deli MA, Nardai S.   +14 more
europepmc   +1 more source

Elevated Endogenous Psychedelic Bufotenine in the Urine of Patients Diagnosed With a Mental Illness: A Systematic Review. [PDF]

Cureus
Clarke AJ.
europepmc   +1 more source

Innovative Psychedelic Therapies: Harnessing 5-MeO-DMT and DMT for Mental Health Treatment. [PDF]

ACS Med Chem Lett
Kargbo RB.
europepmc   +1 more source

Dimethyltryptamine: endogenous role and therapeutic potential

, 2018
openaire   +2 more sources

Active Constituents of Psilocybin Mushroom Edibles.

JAMA Netw Open
van Breemen RB, Simchuk D, Fritzsche B, Huson D, Kuzdzal SA, Ferguson J.   +5 more
europepmc   +1 more source